Stifel analyst Derrick Whitfield lowered the firm’s price target on Aemetis to $9 from $9.80 and keeps a Buy rating on the shares. The firm is updating estimates in its Americas Biofuels coverage following the release of final RVOs from the June 21 RFS final rule announcement for 2023-2025 volumes. The firm views the changes as “undoubtedly positive” for cellulosic fuels like renewable natural gas over the period and negative for advanced biofuels like renewable diesel and biodiesel in the near-term, Stifel tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMTX:
- Aemetis RNG Production Exceeds Plan by 20% During Q2 2023
- Largest borrow rate increases among liquid names
- Aemetis India subsidiary on schedule with biodiesel shipments to OMC customers
- Aemetis India Subsidiary on Schedule with Biodiesel Shipments to OMC Customers: $27 million of Q2 Contracted Deliveries Already Completed
- Aemetis Biogas Achieves Revenue Milestones by Generating Federal RINs and Filing California LCFS Pathway to Begin RNG Revenues in June 2023